The Finance and Accounting team at Intellia Therapeutics is responsible for managing the company’s financial health by overseeing budgeting, financial planning, and reporting. They ensure accurate accounting practices, compliance with regulations, and effective allocation of resources to support the development of innovative gene editing treatments. This team plays a crucial role in strategic decision-making and financial analysis to drive the company's mission forward.
David Towslee
Associate Director, Accounting
Edward Dulac
EVP & CFO
Joseph Snopek
Senior Manager, Financial Repo...
Michael Dube
Vice President, Chief Accounti...
Ray Kelley
Vice President Of Financial Pl...
Sandra Kemp
Senior Manager, Accounting
Stacey Luks
Director, Accounting
Susan Weiner Linscot...
Associate Director Of Financia...
View all